Tauvid Receives Approval for Tau Pathology Imaging

MONDAY, June 1, 2020 -- Tauvid (flortaucipir F18), a radioactive diagnostic agent, was approved to image tau pathology in patients with cognitive impairment being evaluated for Alzheimer disease, the U.S. Food and Drug Administration announced...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news